首页 > 市场调查报告书 > 製药

市场调查报告书

商品编码

1729260

2025-2033年日本肝素市场报告（依产品、来源、给药方式、应用、最终用户、配销通路和地区）

Japan Heparin Market Report by Product, Source, Mode of Administration, Application, End User, Distribution Channel, and Region 2025-2033

出版日期: 2025年05月01日 | 出版商:

IMARC | 英文 121 Pages | 商品交期: 5-7个工作天内

价格

简介目录

2024 年日本肝素市场规模达 3.375 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 6.09 亿美元，2025-2033 年期间的成长率 (CAGR) 为 6.27%。需要抗凝血治疗的心血管疾病（如深部静脉栓塞、肺栓塞）、心房颤动等病例的增加正在推动市场的发展。

肝素是一种广泛使用的抗凝血药物，有助于防止循环系统中血栓的产生。它是一种天然存在的物质，存在于动物的肝臟和肥大细胞中，特别是肺和肠的黏膜。肝素透过抑制凝血酶和其他凝血因子的活性来发挥作用，阻止纤维蛋白原转化为纤维蛋白，这是血块形成的关键步骤。肝素透过静脉或皮下注射给药，常用于各种医疗环境，包括手术、透析以及治疗肺栓塞和深部静脉栓塞等疾病。它被认为是一种速效抗凝血剂，常用于紧急情况下预防危及生命的血栓。然而，其使用需要仔细监测以避免过度出血，并且患者可能需要频繁地进行血液检查以调整剂量。

日本肝素市场趋势：

许多关键因素正在推动日本肝素市场的成长。首先，该地区人口老化导致对肝素治疗的需求增加，因为老年人更容易罹患深部静脉栓塞和肺栓塞等疾病。此外，心血管疾病和癌症等慢性疾病病例的增加也增加了对肝素等抗凝血治疗的需求。此外，抗凝血剂在治疗重症病例中的重要性日益增加，也为市场带来了积极的前景。此外，製药业正在进行的研发工作正在产生肝素的新配方和输送方法，从而提高其有效性和安全性。监管机构还透过执行严格的品质标准和安全法规在推动市场方面发挥关键作用，这激发了医疗保健专业人员和患者的信心。此外，人们对肝素益处的认识不断提高，以及肝素在新兴市场的日益普及，正在推动市场扩张。最后，医疗技术和外科手术的许多进步扩大了肝素的应用范围，促进了其在各种医疗环境中的采用，预计将在未来几年推动日本肝素市场的发展。

日本肝素市场细分：

产品洞察：

普通肝素
低分子量肝素（LMWH）
超低分子量肝素（ULMWH）

来源洞察：

管理模式洞察：

口服
肠外

应用程式洞察：

心房颤动和心臟病发作
中风
深部静脉血栓（DVT）
肺栓塞（PE）
其他的

最终用户洞察：

医院
诊所
家庭护理设置
门诊手术中心
其他的

配销通路洞察：

医院药房
零售药局
药局
网上商店
其他的

竞争格局：

市场研究报告也对竞争格局进行了全面的分析。报告涵盖了市场结构、关键参与者定位、最佳制胜策略、竞争仪表板和公司评估象限等竞争分析。此外，也提供了所有主要公司的详细资料。

本报告回答的关键问题：

日本肝素市场目前表现如何？未来几年将如何表现？
COVID-19对日本肝素市场有何影响？
日本肝素市场依产品划分是怎么样的？
日本肝素市场依来源划分是怎么样的？
根据管理模式，日本肝素市场是如何分類的？
日本肝素市场依应用分類的状况如何？
根据最终用户，日本肝素市场是如何分布的？
日本肝素市场依照配销通路的分布是怎样的？
日本肝素市场的价值链分为哪些阶段？
日本肝素钠的主要驱动因素和挑战是什么？
日本肝素市场的结构是怎么样的？主要参与者是谁？
日本肝素市场竞争程度如何？

本报告回答的关键问题：

日本肝素市场目前表现如何？未来几年将如何表现？
COVID-19对日本肝素市场有何影响？
日本肝素市场依产品划分是怎么样的？
日本肝素市场依来源划分是怎么样的？
根据管理模式，日本肝素市场是如何分類的？
日本肝素市场依应用分類的状况如何？
根据最终用户，日本肝素市场是如何分布的？
日本肝素市场依照配销通路的分布是怎样的？
日本肝素市场的价值链分为哪些阶段？
日本肝素钠的主要驱动因素和挑战是什么？
日本肝素市场的结构是怎么样的？主要参与者是谁？
日本肝素市场竞争程度如何？

Japan heparin market size reached USD 337.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 609.0 Million by 2033, exhibiting a growth rate (CAGR) of 6.27% during 2025-2033. The increasing cases of cardiovascular diseases such as deep vein thrombosis, pulmonary embolism, atrial fibrillation, etc., that require anticoagulant therapy, are driving the market.

Heparin is a widely used anticoagulant medication that helps in preventing the production of blood clots in the circulatory system. It is a naturally occurring substance found in the liver and mast cells of animals, particularly in the mucous membranes of the lungs and intestines. Heparin works by inhibiting the activity of thrombin and other clotting factors, thereby preventing the conversion of fibrinogen into fibrin, a crucial step in blood clot formation. Heparin is administered through intravenous or subcutaneous injection and is commonly employed in various medical settings, including surgeries, dialysis, and as a treatment for ailments, such as pulmonary embolism and deep vein thrombosis. It is considered a fast-acting anticoagulant and is often used in emergency situations to prevent life-threatening clots. However, its use requires careful monitoring to avoid excessive bleeding, and patients may need frequent blood tests to adjust the dosage.

Japan Heparin Market Trends:

Numerous key factors are driving the growth of the heparin market in Japan. Firstly, an aging regional population is contributing to increased demand for heparin-based therapies, as older individuals are more susceptible to conditions like deep vein thrombosis and pulmonary embolism. Additionally, the rising cases of chronic diseases such as cardiovascular disorders and cancer are bolstering the need for anticoagulant treatments like heparin. Furthermore, the rising importance of anticoagulants in managing severe cases is also creating a positive outlook for the market. Moreover, the pharmaceutical industry's ongoing R&D efforts are yielding novel formulations and delivery methods for heparin, enhancing its effectiveness and safety profile. Regulatory agencies are also playing a pivotal role in driving the market by enforcing stringent quality standards and safety regulations, which inspire confidence among healthcare professionals and patients alike. Furthermore, the escalating awareness about the benefits of heparin and its growing availability in emerging markets are fueling market expansion. Lastly, numerous advancements in medical technology and surgical procedures, which have expanded the applications of heparin, promoting its adoption in various medical settings, are expected to drive the heparin market in Japan in the coming years.

Japan Heparin Market Segmentation:

Product Insights:

Unfractionated Heparin
Low Molecular Weight Heparin (LMWH)
Ultra-Low Molecular Weight Heparin (ULMWH)

Source Insights:

Bovine
Porcine

Mode of Administration Insights:

Oral
Parenteral

Application Insights:

Atrial Fibrillation and Heart Attack
Stroke
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Others

End User Insights:

Hospitals
Clinics
Homecare Settings
Ambulatory Surgical Centers
Others

Distribution Channel Insights:

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Stores
Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan heparin market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan heparin market?
What is the breakup of the Japan heparin market on the basis of product?
What is the breakup of the Japan heparin market on the basis of source?
What is the breakup of the Japan heparin market on the basis of mode of administration?
What is the breakup of the Japan heparin market on the basis of application?
What is the breakup of the Japan heparin market on the basis of end user?
What is the breakup of the Japan heparin market on the basis of distribution channel?
What are the various stages in the value chain of the Japan heparin market?
What are the key driving factors and challenges in the Japan heparin?
What is the structure of the Japan heparin market and who are the key players?
What is the degree of competition in the Japan heparin market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Heparin Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Heparin Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Heparin Market - Breakup by Product

6.1 Unfractionated Heparin
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Low Molecular Weight Heparin (LMWH)
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Ultra-Low Molecular Weight Heparin (ULMWH)
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)

7 Japan Heparin Market - Breakup by Source

7.1 Bovine
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Porcine
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)

8 Japan Heparin Market - Breakup by Mode of Administration

8.1 Oral
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Parenteral
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)

9 Japan Heparin Market - Breakup by Application

9.1 Atrial Fibrillation and Heart Attack
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Stroke
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Deep Vein Thrombosis (DVT)
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
9.4 Pulmonary Embolism (PE)
- 9.4.1 Overview
- 9.4.2 Historical and Current Market Trends (2019-2024)
- 9.4.3 Market Forecast (2025-2033)
9.5 Others
- 9.5.1 Historical and Current Market Trends (2019-2024)
- 9.5.2 Market Forecast (2025-2033)

10 Japan Heparin Market - Breakup by End User

10.1 Hospitals
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Forecast (2025-2033)
10.2 Clinics
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)
10.3 Homecare Settings
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2019-2024)
- 10.3.3 Market Forecast (2025-2033)
10.4 Ambulatory Surgical Centers
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2019-2024)
- 10.4.3 Market Forecast (2025-2033)
10.5 Others
- 10.5.1 Historical and Current Market Trends (2019-2024)
- 10.5.2 Market Forecast (2025-2033)

11 Japan Heparin Market - Breakup by Distribution Channel

11.1 Hospital Pharmacies
- 11.1.1 Overview
- 11.1.2 Historical and Current Market Trends (2019-2024)
- 11.1.3 Market Forecast (2025-2033)
11.2 Retail Pharmacies
- 11.2.1 Overview
- 11.2.2 Historical and Current Market Trends (2019-2024)
- 11.2.3 Market Forecast (2025-2033)
11.3 Drug Stores
- 11.3.1 Overview
- 11.3.2 Historical and Current Market Trends (2019-2024)
- 11.3.3 Market Forecast (2025-2033)
11.4 Online Stores
- 11.4.1 Overview
- 11.4.2 Historical and Current Market Trends (2019-2024)
- 11.4.3 Market Forecast (2025-2033)
11.5 Others
- 11.5.1 Historical and Current Market Trends (2019-2024)
- 11.5.2 Market Forecast (2025-2033)

12 Japan Heparin Market - Competitive Landscape

12.1 Overview
12.2 Market Structure
12.3 Market Player Positioning
12.4 Top Winning Strategies
12.5 Competitive Dashboard
12.6 Company Evaluation Quadrant

13 Profiles of Key Players

13.1 Company A
- 13.1.1 Business Overview
- 13.1.2 Product Portfolio
- 13.1.3 Business Strategies
- 13.1.4 SWOT Analysis
- 13.1.5 Major News and Events
13.2 Company B
- 13.2.1 Business Overview
- 13.2.2 Product Portfolio
- 13.2.3 Business Strategies
- 13.2.4 SWOT Analysis
- 13.2.5 Major News and Events
13.3 Company C
- 13.3.1 Business Overview
- 13.3.2 Product Portfolio
- 13.3.3 Business Strategies
- 13.3.4 SWOT Analysis
- 13.3.5 Major News and Events
13.4 Company D
- 13.4.1 Business Overview
- 13.4.2 Product Portfolio
- 13.4.3 Business Strategies
- 13.4.4 SWOT Analysis
- 13.4.5 Major News and Events
13.5 Company E
- 13.5.1 Business Overview
- 13.5.2 Product Portfolio
- 13.5.3 Business Strategies
- 13.5.4 SWOT Analysis
- 13.5.5 Major News and Events

14 Japan Heparin Market - Industry Analysis

14.1 Drivers, Restraints and Opportunities
- 14.1.1 Overview
- 14.1.2 Drivers
- 14.1.3 Restraints
- 14.1.4 Opportunities
14.2 Porters Five Forces Analysis
- 14.2.1 Overview
- 14.2.2 Bargaining Power of Buyers
- 14.2.3 Bargaining Power of Suppliers
- 14.2.4 Degree of Competition
- 14.2.5 Threat of New Entrants
- 14.2.6 Threat of Substitutes
14.3 Value Chain Analysis